Also trades as: TELO.V (TSXV) · $vol 0M
TDSGF OTC
Telo Genomics Corp.
1W: -9.8%
1M: +55.4%
3M: +21.6%
YTD: -44.1%
1Y: -37.3%
3Y: -88.2%
$0.03
+0.01 (+27.27%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$11K
+0.0% ▲
Operating Income
-$3M
+3.5% ▲
Net Income
-$3M
-0.2% ▼
EPS (Diluted)
$-0.02
+40.0% ▲
EBITDA
-$3M
-0.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $65K | $62K | $33K | $0 | $11K |
| Gross Profit | -$65K | -$62K | -$33K | $0 | -$11K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $365K | $604K | $1M | $1M | $1M |
| SG&A Expenses | $946K | $653K | $1M | $1M | $958K |
| Operating Expenses | $1M | $1M | $3M | $3M | $2M |
| Operating Income | -$1M | -$1M | -$3M | -$3M | -$3M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $27K | $0 | $5K | $5K | $4K |
| Income Before Tax | -$1M | -$1M | -$3M | -$3M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$1M | -$3M | -$3M | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.04 | $-0.02 | $-0.05 | $-0.04 | $-0.02 |
| EBITDA | -$1M | -$1M | -$3M | -$3M | -$3M |
| Shares Outstanding | 41M | 47M | 60M | 71M | 88M |